Patients were randomised ( 2:2:1 ) to receive fesoterodine 8 mg , fesoterodine 4 mg , or placebo once daily ; those randomised to fesoterodine 8 mg started with fesoterodine 4 mg once daily for 1 week , then 8 mg once daily for the remaining 11 weeks .